Affiliation:
1. Lucerne Cantonal Hospital
2. University Hospital Leipzig
Abstract
AbstractPurpose Mesonephric-like adenocarcinomas (MLA) of the female genital tract represent a rare and relatively recently described neoplasm exhibiting characteristic morphologic and immunohistochemical findings commonly associated with aKRAS-mutation. Most cases display an aggressive clinical behavior, but knowledge about treatment approaches is limited, especially for targetingKRAS. Methods We report a series of eight cases with a detailed molecular analysis forKRAS. These cases as well as the data of previously published cases with detailed information regardingKRAS-mutational events were reviewed for a potential targeted approach and its prognostic impact. Results Both the uterine and ovarian MLA harbor a somaticKRASmutation in about 85% of the reported cases, affecting the hotspot codons 12 and 13. 15.7% of the endometrial and 15.6% of ovarian MLA are wildtype forKRAS. A p.G12A-alteration was seen in 5.6% (5/89) of the endometrial and in 6.2% (2/32) of the ovarian tumors, for p.G12C in 7.9% and 6.2%, for p.G12D in 32.6% and 34.5% and for p.G12V in 36% and 37.5%, respectively. Very limited data are available regarding the prognostic impact of different mutational sites within theKRASgene without significant prognostic impact. Conclusion Because of a specific p.G12C-KRASsomatic mutation, only the minority of MLA (7.9% with uterine and 6.2% with ovarian primary) are potentially targetable by sotarasib in that rare but aggressive subtype of adenocarcinoma of the female genital tract. Until now, the different location of a somaticKRAS-mutation is of no prognostic impact.
Publisher
Research Square Platform LLC
Reference47 articles.
1. Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract;Mirkovic J;Am J Surg Pathol,2018
2. Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas;McFarland M;Histopathology.,2016
3. McCluggage WG. Mesonephric-like Adenocarcinoma of the Female Genital Tract: From Morphologic Observations to a Well-characterized Carcinoma With Aggressive Clinical Behavior. Adv Anat Pathol. 2022 Jul 1;29(4):208–216.
4. Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Immunohistochemical Analyses Using Markers for Mesonephric, Endometrioid and Serous Tumors. Diagnostics (Basel);Kim H,2021
5. Mesonephric-like Carcinoma of the Endometrium: A Subset of Endometrial Carcinoma With an Aggressive Behavior;Euscher ED;Am J Surg Pathol,2020